A. Kontush and M. J. Chapman, High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics, p.648, 2012.

T. F. Luscher, U. Landmesser, A. Von-eckardstein, and A. M. Fogelman, High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target, Diabetes Care, vol.36, issue.1, pp.4-10, 2013.

M. Guerin, P. J. Dolphin, and M. J. Chapman, Preferential cholesteryl ester acceptors among the LDL subspecies of subjects with familial hypercholesterolemia, Arterioscler Thromb, vol.14, pp.679-685, 1994.

M. J. Chapman, S. Goldstein, D. Lagrange, and P. M. Laplaud, A density gradient Lipid Res, vol.22, pp.339-58, 1981.

M. Guerin, E. Bruckert, P. J. Dolphin, G. Turpin, and M. J. Chapman, Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia, Arterioscler Thromb Vasc Biol, vol.16, pp.763-72, 1996.

F. Rached, M. Lhomme, L. Camont, F. Gomes, C. Dauteuille et al.,

P. Lesnik, C. V. Serrano, J. Chapman, M. J. Kontush, and A. , Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A, Biochim Biophys Acta, vol.1851, pp.1254-61, 2015.

K. Chapman, M. J. High-density-lipoproteins-;-ko, D. T. Alter, D. A. Guo, H. Koh et al., High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study, Structure, Metabolism, References, vol.1, pp.2073-83, 2016.

C. M. Madsen, A. Varbo, and N. Bg, Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies, Eur Heart J, vol.38, issue.32, pp.2478-86, 2017.